Stillpoint founder Eric Wong reveals major China tech investment strategy

Eric Wong will present his investment case at the Sohn Hearts & Minds conference at the Sydney Opera House on Friday, November 14.
Stillpoint Investments founder and chief investment officer Eric Wong. Picture: Jaclyn Licht

David Rogers

Stillpoint founder Eric Wong reveals major China tech investment strategy

September 25, 2025
Eric Wong will present his investment case at the Sohn Hearts & Minds conference at the Sydney Opera House on Friday, November 14.
Read Transcript

Eric Wong has seen plenty of market cycles. The founder of Stillpoint Investments cut his teeth during the global financial crisis, working for legendary hedge fund manager John Griffin at Blue Ridge Capital, himself a protégé of the great Julian Robertson of Tiger Management.

Now Wong is betting big on China. His Greater China equity fund is capitalising on what he sees as a once-in-a-decade opportunity as Chinese tech stocks surge from bargain valuation levels.

“China’s markets continue to trade at a meaningful discount to the S&P,” Wong says. “It’s trading at a PE ratio of 12 to 13 times, whereas the US is approaching the mid-20s. From a cash flow yield perspective, China’s trading at seven-plus per cent and the US is at slightly less than three per cent.”

“You almost are able to get a 50 per cent discount on the broader market.”

Wong spent 11 years at Blue Ridge Capital, where Griffin built a track record of 15.4 per cent annual returns over two decades. Griffin’s influence on Wong went beyond just investing.

“His influence on me has been holistic in so many different ways, beyond just investing — thinking about life and wellness and how that actually enhances how we think about the investment landscape,” Wong tells The Australian.

The experience shaped Wong’s approach at Stillpoint, which he founded in 2022.

Like his mentor, Wong is a generalist who goes where the opportunities are richest.

Currently, that’s artificial intelligence infrastructure in China. The numbers are staggering.

“What we’re seeing happening in China is the hyperscalers, like the ByteDances and the Alibabas, are actually expanding their AI infrastructure capital expenditure dramatically,” Wong says.

“This year, the broader capex is going up by 60 per cent year-on-year.”

These data centre companies are trading at just 12 to 13 times EBITDA, compared to their global peers at well above 20 times.

The geopolitical headlines around chip bans have also created opportunities.

“The news around the chip bans will create uncertainty from market perception in terms of how sustainable this growth is,” he says. “But, from our perspective, it’s more around the matter of which chips they use. They will still need the data centres.”

Wong’s second major theme is precision manufacturing. Companies operating in the space help expand manufacturing capacity outside China as supply chains reshape in an increasingly multipolar world.

“These are businesses that are actually helping expand manufacturing capacity in markets outside of China,” he says. “When you think about the reshaping of what manufacturing looks like in a more de-globalised world, these businesses are actually in a position to benefit during this geopolitical tension.”

These companies trade at single-digit price-to-earnings multiples and pay dividend yields of eight to nine per cent. His conviction comes from seeing China’s technological advancement first-hand during his frequent visits. While based in New York City, Wong spends about a third of his time in China.

The technology integration into daily life is remarkable. At hotels, robots deliver room service from ground-floor cabinets to guest rooms. Hotel TVs show real-time availability of washing machines so guests don’t waste trips to the laundry.

“I think what I’m trying to illustrate is that the ease of life that is brought by technology, even in the simplest ways, helps improve efficiency and lower inconvenience,” Wong says.

“These types of use cases from a consumer perspective are actually very present in day-to-day life.”

As evidence the long winter for Chinese equities may be ending, he notes southbound liquidity flowing into Hong Kong this year has already surpassed all of 2024. IPO activity has also picked up and margin trading is increasing sustainably.

Most tellingly, Chinese household deposits fell for two consecutive months recently, with money shifting into equity markets.

“I’ve always viewed that this closing of winter in Chinese equity markets needs to be led by the domestic investor,” Wong says. For global investors, Wong believes China simply can’t be ignored.

“It’s a market you can’t ignore — second largest economy in the world. It’s a place that I think every investor has to visit, at the very least. From an allocation perspective, what we’ve seen over recent years in terms of foreign capital fleeing, I think that’s certainly worth revisiting.”

Eric Wong will present his investment case at the Sohn Hearts & Minds conference at the Sydney Opera House on Friday, November 14, 2025.

The annual conference features stock picks from leading global investment experts, with all profits donated to medical research.

This year marks 10 years of the conference, which has raised over $83.7m.

This article was originally posted by The Australian here.

Licensed by Copyright Agency. You must not copy this work without permission.

Eric Wong has seen plenty of market cycles. The founder of Stillpoint Investments cut his teeth during the global financial crisis, working for legendary hedge fund manager John Griffin at Blue Ridge Capital, himself a protégé of the great Julian Robertson of Tiger Management.

Now Wong is betting big on China. His Greater China equity fund is capitalising on what he sees as a once-in-a-decade opportunity as Chinese tech stocks surge from bargain valuation levels.

“China’s markets continue to trade at a meaningful discount to the S&P,” Wong says. “It’s trading at a PE ratio of 12 to 13 times, whereas the US is approaching the mid-20s. From a cash flow yield perspective, China’s trading at seven-plus per cent and the US is at slightly less than three per cent.”

“You almost are able to get a 50 per cent discount on the broader market.”

Wong spent 11 years at Blue Ridge Capital, where Griffin built a track record of 15.4 per cent annual returns over two decades. Griffin’s influence on Wong went beyond just investing.

“His influence on me has been holistic in so many different ways, beyond just investing — thinking about life and wellness and how that actually enhances how we think about the investment landscape,” Wong tells The Australian.

The experience shaped Wong’s approach at Stillpoint, which he founded in 2022.

Like his mentor, Wong is a generalist who goes where the opportunities are richest.

Currently, that’s artificial intelligence infrastructure in China. The numbers are staggering.

“What we’re seeing happening in China is the hyperscalers, like the ByteDances and the Alibabas, are actually expanding their AI infrastructure capital expenditure dramatically,” Wong says.

“This year, the broader capex is going up by 60 per cent year-on-year.”

These data centre companies are trading at just 12 to 13 times EBITDA, compared to their global peers at well above 20 times.

The geopolitical headlines around chip bans have also created opportunities.

“The news around the chip bans will create uncertainty from market perception in terms of how sustainable this growth is,” he says. “But, from our perspective, it’s more around the matter of which chips they use. They will still need the data centres.”

Wong’s second major theme is precision manufacturing. Companies operating in the space help expand manufacturing capacity outside China as supply chains reshape in an increasingly multipolar world.

“These are businesses that are actually helping expand manufacturing capacity in markets outside of China,” he says. “When you think about the reshaping of what manufacturing looks like in a more de-globalised world, these businesses are actually in a position to benefit during this geopolitical tension.”

These companies trade at single-digit price-to-earnings multiples and pay dividend yields of eight to nine per cent. His conviction comes from seeing China’s technological advancement first-hand during his frequent visits. While based in New York City, Wong spends about a third of his time in China.

The technology integration into daily life is remarkable. At hotels, robots deliver room service from ground-floor cabinets to guest rooms. Hotel TVs show real-time availability of washing machines so guests don’t waste trips to the laundry.

“I think what I’m trying to illustrate is that the ease of life that is brought by technology, even in the simplest ways, helps improve efficiency and lower inconvenience,” Wong says.

“These types of use cases from a consumer perspective are actually very present in day-to-day life.”

As evidence the long winter for Chinese equities may be ending, he notes southbound liquidity flowing into Hong Kong this year has already surpassed all of 2024. IPO activity has also picked up and margin trading is increasing sustainably.

Most tellingly, Chinese household deposits fell for two consecutive months recently, with money shifting into equity markets.

“I’ve always viewed that this closing of winter in Chinese equity markets needs to be led by the domestic investor,” Wong says. For global investors, Wong believes China simply can’t be ignored.

“It’s a market you can’t ignore — second largest economy in the world. It’s a place that I think every investor has to visit, at the very least. From an allocation perspective, what we’ve seen over recent years in terms of foreign capital fleeing, I think that’s certainly worth revisiting.”

Eric Wong will present his investment case at the Sohn Hearts & Minds conference at the Sydney Opera House on Friday, November 14, 2025.

The annual conference features stock picks from leading global investment experts, with all profits donated to medical research.

This year marks 10 years of the conference, which has raised over $83.7m.

This article was originally posted by The Australian here.

Licensed by Copyright Agency. You must not copy this work without permission.

Disclaimer: This material has been prepared by The Australian, published on Sep 25, 2025. HM1 is not responsible for the content of linked websites or content prepared by third party. The inclusion of these links and third-party content does not in any way imply any form of endorsement by HM1 of the products or services provided by persons or organisations who are responsible for the linked websites and third-party content. This information is for general information only and does not consider the objectives, financial situation or needs of any person. Before making an investment decision, you should read the relevant disclosure document (if appropriate) and seek professional advice to determine whether the investment and information is suitable for you.

facebook
linkedin
All
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
November 5, 2023

Five Secrets To Delivering The Perfect Pitch

Australia’s best stock pickers have just eight minutes to convince the country’s top money managers they have found an investment gem that the market has overlooked.

Read More
November 2, 2023

Meet the 2023 Conference Managers

Following a rigorous global search, the Conference Fund Manager Selection Committee is pleased to share ten new managers for 2023.

Read More
Daniel Loeb oversees $US11.7 billion ($18.5 billion) at New York-based Third Point. Picture: BloombergDaniel Loeb oversees $US11.7 billion ($18.5 billion) at New York-based Third Point. Picture: BloombergDaniel Loeb oversees $US11.7 billion ($18.5 billion) at New York-based Third Point. Picture: BloombergDaniel Loeb oversees $US11.7 billion ($18.5 billion) at New York-based Third Point. Picture: Bloomberg
October 23, 2023

Dan Loeb to headline Sohn Hearts & Minds

Famed hedge fund manager Dan Loeb has been named as one of the headline acts for next month’s Sohn Hearts & Minds philanthropic investment conference to be held in Sydney.

Read More
October 23, 2023

US Bank Run Has Slowed To A Walk, But Instability Remains

When Ravi Chopra reveals his stock pick at the prestigious Sohn Hearts & Minds conference at the Opera House in Sydney next month, it could well be a short bet on a US bank.

Read More
October 18, 2023

Two small caps: Propel Funeral Services (ASX: PFP) and Clarity Pharmaceuticals (ASX: CU6)

Get to know our 2023 Conference Fund Manager Rikki Bannan of IFM Investors who recently featured on the Equity Mates Media podcast.

Read More
October 16, 2023

How this hedge fund pulled off 2023’s ‘big short’

Last year, Ravi Chopra was travelling through Europe to shop his latest short idea to potential investors. “Financials are really all in the weeds,” he told The Australian Financial Review in an interview from New York.

Read More
October 10, 2023

Beware the pitfalls of investing in healthcare, says IFM boss

“Healthcare is often viewed as a stable, defensive sector to invest in, but in small caps that hasn’t necessarily proven to be the case,” she says in an interview ahead of her appearance at the Sohn Hearts & Minds Conference 2023.

Read More
October 6, 2023

Secret to a long life cheaper than you think celebrity physician Peter Attia reveals

Don't miss Dr Peter Attia who will speak at the Sohn Hearts & Minds Conference at the Sydney Opera House next month.

Read More
September 18, 2023

‘Volatility is opportunity’: why this manager loves shorting stocks

Angela Aldrich of Bayberry Capital Partners LP bet against Treasury Wine Estates at the top of the market and now she's preparing to make her next big call at this year's Sohn Hearts & Minds Conference.

Read More
September 15, 2023

Top fund managers share 11 stock picks for the long term

After a dramatic earnings season, fund managers, including Jessica Farr-Jones of Regal Funds and Kieran Moore of Munro Partners (HM1 Core Fund Managers), have shared some of their top picks for long-term growth.

Read More
September 11, 2023

Investors Sweeten On Hedge Funds As Rates Climb

After a decade of easy money pushing equity markets in one direction, Wall Street hedge fund manager Ricky Sandler says the return of volatility and higher interest rates is seeing money return to long-short strategies.

Read More
September 11, 2023

Stock Stars Look Under The Surface

Influential New York-hedge fund manager Ricky Sandler returns to Australia to make a new pick at this year’s Sohn Hearts & Minds conference that will be held at the Sydney Opera House on November 17.

Read More
Barrenjoey co-executive chairman Matthew Grounds and New York-based Eminence Capital fund manager Ricky Sandler will be at the eighth Sohn Hearts & Minds conference. Picture: Peter RaeBarrenjoey co-executive chairman Matthew Grounds and New York-based Eminence Capital fund manager Ricky Sandler will be at the eighth Sohn Hearts & Minds conference. Picture: Peter RaeBarrenjoey co-executive chairman Matthew Grounds and New York-based Eminence Capital fund manager Ricky Sandler will be at the eighth Sohn Hearts & Minds conference. Picture: Peter RaeBarrenjoey co-executive chairman Matthew Grounds and New York-based Eminence Capital fund manager Ricky Sandler will be at the eighth Sohn Hearts & Minds conference. Picture: Peter Rae
September 11, 2023

Top Ny Stock Picker Warns Inflation To Remain Above Pre-Covid Levels

Influential New York hedge fund manager Ricky Sandler of Eminence Capital returns for the 2023 Sohn Hearts & Minds Conference in Sydney and says no one is focused on picking interesting, idiosyncratic stocks.

Read More
August 4, 2023

New Relic

New Relic was pitched by Ricky Sandler of Eminence Capital at the 2022 Sohn Hearts & Minds Conference.

Read More
June 18, 2023

Investors can’t agree how to value the world’s hottest stock

Despite mixed investor opinions, Munro Partners (Core Fund Manager) remains a strong believer in Nvidia. They are standing firm in their investment and still consider it a solid buy.

Read More
December 10, 2024

Professor Jane Butler: Sparking Hope for Spinal Cord Injuries

In this episode of the Hearts & Minds Podcast, we sit down with Professor Jane Butler to discuss her groundbreaking research into spinal cord injuries.

Read More
impact-podcasts
September 24, 2024

Asian Market Potential with Tom Naughton of Prusik

CIO Charlie Lanchester sits down with Tom Naughton, CIO of Prusik Investment Mgmt. Tom shares his investment philosophy, the opportunities and challenges in Asian markets, and how his 2023 conference stock pick, Swire Pacific (0019.HK), delivered an impressive 30% return.

Read More
investing
September 4, 2024

Building Hearts and Minds with Co-Founders Matthew Grounds and Guy Fowler

In this episode, co-founders Matthew Grounds AM and Guy Fowler OAM discuss their journey in building Hearts & Minds and its philanthropic model that has donated over $70 million to medical research.

Read More
investing
June 25, 2024

Navigating the Resource Sector with Jeremy Bond of Terra Capital

In this episode, we chat with Jeremy Bond, Founder of Terra Capital and HM1 Conference Fund Manager. Tune in for insights into the world of resource investments and the exciting opportunities that lie ahead.

Read More
investing
June 11, 2024

Prof. Nadia Badawi on Cerebral Palsy Breakthroughs and Neonatal Care

Dive deep into the groundbreaking work of Professor Nadia Badawi, an internationally recognised neonatologist and expert in Cerebral Palsy.

Read More
impact-podcasts
May 28, 2024

Investment Insights: Rikki Bannan on Top Picks and Trends

Join us for an engaging episode featuring Rikki Bannan, Portfolio Manager of IFM Investors and HM1 Conference Fund Manager. This episode explores Rikki's career journey, investment strategies, and her 2023 conference stock pick, Telix Pharmaceuticals (ASX.TLX).

Read More
investing
December 6, 2023

Peter Cooper talks building and instilling a culture of humility and excellence

In this episode, our guest is the renowned investor, Peter Cooper, founder and Chief Investment Officer of Cooper Investors (Core Fund Manager). A founding supporter of Hearts and Minds, Peter is a staunch advocate of our model and its philanthropic purpose, actively engaging in every facet of Hearts and Minds.

Read More
investing
November 28, 2023

Jun Bei Liu on her high conviction investment strategy

In this episode, HM1 Chief Investment Officer Charlie Lanchester is joined by Jun Bei Liu. Jun Bei is the Portfolio Manager of Tribeca’s Alpha Plus Fund and since taking over managing the Fund, she has quadrupled AUM.

Read More
investing
November 21, 2023

The world of rare genetic disease research

In this episode, we speak to Associate Professor Gina Ravenscroft. Gina is an Associate Professor in Neurogenetics at the Harry Perkins Institute of Medical Research in Perth. Her research interests are in rare genetic diseases, with a particular focus on neurogenetic diseases in babies and children.

Read More
impact-podcasts
November 14, 2023

Learn what makes a high conviction investment and how to avoid short-term noise

In this episode, our Core Fund Manager Magellan shares how they select top stocks for the HM1 portfolio.

Read More
investing
November 7, 2023

Delve into the world of kids critical care and trauma research

In thie episode, we are joined by Dr. Marino Festa, or Rino for short. He is the Medical Director of NSW Kids ECMO Referral Service and a senior specialist in Paediatric Intensive Care at Children’s Hospital at Westmead.

Read More
impact-podcasts
October 31, 2023

Where Regal's Phil King is searching for opportunities

HM1's CIO, Charlie Lanchester, talks to Phil King of Regal Funds about his passion for stocks, his ongoing search for opportunities, and some of the sectors he’s excited by right now. Phil King of Regal Funds, has been a tremendous supporter of Hearts & Minds since the beginning.

Read More
investing
October 24, 2023

Preventing recurrent miscarriages and birth defects

In this episode, CEO Paul Rayson is joined by renowned biomedical researcher Professor Sally Dunwoodie. Prof. Dunwoodie's groundbreaking work has revolutionised clinical practices and enabled genetic diagnostic tests worldwide. In 2017, her team achieved a double breakthrough with the potential to prevent recurrent miscarriages and various birth defects.

Read More
impact-podcasts
October 17, 2023

Nick Griffin on how he finds global winners

In this episode, CIO Charlie Lanchester chats with Nick Griffin, the founding partner and CIO of Munro Partners, one of HM1's Core Fund Managers. They go over his career to date, reflect on the lessons he’s learned, and trace the decisions that led to him starting Munro.

Read More
investing
October 10, 2023

How A/Prof Matt Call is teaching our body to kill cancer

In this episode, CEO Paul Rayson is joined by WEHI’s Associate Professor Matt Call to talk about his incredible research. Matt’s team teaches and trains the body's own immune cells to target and kill cancer cells.

Read More
impact-podcasts

No results found.

Please try a different search keyword or filter.